Company intelligence
IQVIA Italia
Accelerate innovation for a healthier world.
About IQVIA Italia
Quintiles e IMS Health si sono unite per diventare IQVIA, The Human Data Science Company™. Motivati dal settore che aiutiamo, ci impegniamo a fornire soluzioni che permettano alle aziende Life Sciences di innovare con maggiore sicurezza, massimizzare le opportunità e, in definitiva, evolvere il mondo della salute. Forniamo soluzioni che trasformano in risultati tangibili la potenza del nostro IQVIA CORE™: - Domain expertise: profonda conoscenza globale dell’ambito healthcare, su aree terapeutiche e metodi scientifici - Advanced Analytics: reporting avanzato per il mondo della salute, disegnato per prendere decisioni più rapide e precise - Unparalleled Data: una delle raccolte di dati healthcare più ampia del pianeta, gestita con innovativi sistemi di data protection - Transformative Technology: tecnologie di ultima generazione per fornire accesso real time alle informazioni chiave Per saperne di più, visita www.IQVIA.com
Verified activity
Signals from IQVIA Italia
11 published signals
Research & Knowledge
IQVIA Italia published an article in the Journal of Nephrology titled Healthcare cost offsets associated with empagliflozin for the treatment of chronic kidney disease in Italy: a budget impact analysis.
Reported by IQVIA Italia
Sales & Marketing
IQVIA Italia reported that the last week closed at 495.5 million euros with a 3.6% increase compared to the previous year.
Reported by IQVIA Italia
Sales & Marketing
IQVIA Italia reported that the commercial growth remains positive with a 1.0% YTD growth and 3.4% weekly growth.
Reported by IQVIA Italia
Sales & Marketing
IQVIA Italia reported that the YTD value for the market pharmacy grew by 4.4% to 19.2 billion euros.
Reported by IQVIA Italia
Sales & Marketing
IQVIA Italia reported that the Solari continue to benefit from the seasonality with a 33.8% growth in the last week.
Reported by IQVIA Italia
Sales & Marketing
IQVIA Italia reported that the Personal Care strengthens the trend with a 2.5% YTD growth and 6.2% growth in the last week.
Reported by IQVIA Italia
Sales & Marketing
IQVIA Italia reported that the Insetto-Repellents remain negative at 17.5 million euros with a 9.1% loss in the YTD, but show a decisive recovery in the last review reaching a 29.4% increase compared to the previous year.
Reported by IQVIA Italia
Sales & Marketing
IQVIA Italia reported that the Etico remains the main driver of the channel with a 7.0% YTD growth and 3.7% growth in the last review.
Reported by IQVIA Italia
Presence & Recognition
IQVIA Italia is hosting a webinar titled Launch in the Era of AI on September 23, 2026, featuring experts to share new insights on AI usage by healthcare professionals, information search behavior, and product visibility.
Reported by IQVIA Italia
People
IQVIA Italia celebrated its 10th anniversary of service with Rosalba Domanico.
Reported by Rosalba Domanico
Presence & Recognition
IQVIA Italia is hosting an event on September 22, 2026, at its Milan offices, featuring a morning session on compliance evolution for MedTech companies.
Reported by IQVIA Italia